Roy Blunt Sells 600 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) Director Roy Blunt sold 600 shares of the business’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $262.68, for a total value of $157,608.00. Following the sale, the director owned 4,589 shares in the company, valued at approximately $1,205,438.52. This represents a 11.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Tenet Healthcare Stock Up 2.4%

Shares of THC stock opened at $262.75 on Friday. The stock has a market cap of $21.16 billion, a P/E ratio of 10.13, a price-to-earnings-growth ratio of 1.00 and a beta of 1.23. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The stock has a fifty day moving average price of $200.19 and a 200 day moving average price of $201.39. Tenet Healthcare Corporation has a one year low of $157.58 and a one year high of $265.32.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same quarter in the prior year, the company posted $4.02 EPS. The business’s revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts predict that Tenet Healthcare Corporation will post 21.09 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. PeakShares LLC increased its holdings in Tenet Healthcare by 3.3% during the 1st quarter. PeakShares LLC now owns 1,693 shares of the company’s stock valued at $319,000 after purchasing an additional 54 shares in the last quarter. Sanctuary Advisors LLC boosted its stake in Tenet Healthcare by 0.5% in the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock worth $2,246,000 after purchasing an additional 57 shares in the last quarter. Quadrant Capital Group LLC grew its holdings in shares of Tenet Healthcare by 0.7% during the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after purchasing an additional 58 shares during the last quarter. Applied Finance Capital Management LLC raised its holdings in shares of Tenet Healthcare by 3.8% in the first quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock valued at $310,000 after buying an additional 60 shares during the last quarter. Finally, Syon Capital LLC lifted its position in Tenet Healthcare by 5.3% during the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock worth $249,000 after buying an additional 63 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have weighed in on THC shares. The Goldman Sachs Group reaffirmed a “buy” rating and set a $305.00 price objective on shares of Tenet Healthcare in a report on Tuesday, July 28th. Guggenheim raised their target price on Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a research report on Tuesday, July 28th. Piper Sandler set a $308.00 price target on Tenet Healthcare in a research report on Monday, July 27th. Robert W. Baird increased their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 28th. Finally, Royal Bank Of Canada boosted their target price on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a research note on Monday, July 27th. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $271.00.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.